Background Image
Previous Page  25 / 30 Next Page
Information
Show Menu
Previous Page 25 / 30 Next Page
Page Background

25

7.

Saiz A, Zuliani L, Blanco Y, Tavolato B, Giometto

B, Graus F, et al. Revised diagnostic criteria for

neuromyelitis optica (NMO).Application in a

series of suspected patients. J Neurol

2007;254:1233-7.

9.

Fazio R, Malosio ML, Lampasona V, De Feo D,

Privitera D, Marnetto F, et al. Antiacquaporin 4

antibodies detection by different techniques in

neuromyelitis optica patients. Mult Scler

2009;15:1153-63.

10.

Jarius S, Aboul-Enein F, Waters P, Kuenz B,

Hauser A, Berger T, et al. Antibody to

aquaporin-4 in the long-term course of

neuromyelitis optica. Brain 2008;131(Pt 11):3072-

80.

11.

Balcer LJ, Galetta SL. Treatment of acute

demyelinating optic neuritis. Semin Ophthalmol

2002;17:4-10.

12.

Takahashi T, Fujihara K, Nakashima I, Misu T,

Miyazawa I, Nakamura M, et al. Anti-

aquaporin-4 antibody is involved in the

pathogenesis of NMO: a study on antibody titre.

Brain 2007;130(Pt 5):1235-43.

13.

Kapoor R, Miller DH, Jones SJ, Plant GT, Brusa

A, Gass A, et al. Effects of intravenous

methylprednisolone on outcome in MRI-based

prognostic subgroups in acute optic neuritis.

Neurology 1998;50:230-7.